Skip to main content
Fig. 1 | Critical Care

Fig. 1

From: Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study

Fig. 1

a Overall survival plot during the hospital stay comparing patients who received thiamine (88 patients) as adjunctive therapy versus the control group (650 patients)—before PS matching. b Overall survival plot during the hospital stay comparing patients who received thiamine (83 patients) as adjunctive therapy versus the control group (83 patients)—after PS matching

Back to article page